Impact of a Pharmacist-Led Chronic Disease State Management Clinic on Patient Assessment of Chronic Illness Care

Impact of a Pharmacist-Led Chronic Disease State Management Clinic on Patient Assessment of Chronic Illness Care

Background: The Patient Assessment of Chronic Illness Care (PACIC) tool measures patient satisfaction with chronic disease care. Objective: A modified PACIC tool (PACIC-RxFM) was used to assess patient satisfaction in a pharmacist-led chronic disease state management clinic. The secondary outcome co...

Full description

Bibliographic Details
Main Authors:	Emily M Buatois PharmD, BCPS, Les P Covington PharmD, BCACP, BCGP, Nicole D Lopez MD, FAAFP, Rodney B Young MD, FAAFP, Eric J MacLaughlin PharmD, FASHP, FCCP, BCPS
Format:	Article
Language:	English
Published:	SAGE Publishing 2022-06-01
Series:	Journal of Patient Experience
Online Access:	https://doi.org/10.1177/23743735221105682

Similar Items

Impact of a pharmacist-driven tardive dyskinesia screening service
by: Niyati Butala, PharmD, BCPP, et al.
Published: (2021-07-01)

The Role of Ambulatory Care Pharmacists in an HIV Multidisciplinary Team within a Free and Bilingual Clinic
by: Ann M. Fugit, Pharm.D., BCPS, et al.
Published: (2013-01-01)

Social Media and Unprofessional Pharmacist Conduct: A Cross-Sectional Survey of Boards of Pharmacy
by: Lindsey Elmore, PharmD, BCPS, et al.
Published: (2013-01-01)

Impact of Vitamin K Administration on Elevated International Normalized Ratio in Chronic Liver Disease
by: Carmen B. Smith PharmD, BCPS, et al.
Published: (2023-04-01)

Enteral Administration of Twice-Daily Dolutegravir and Rilpivirine as a Part of a Triple-Therapy Regimen in a Critically Ill Patient with HIV
by: Sarah Lynn Turley PharmD, BCPS, et al.
Published: (2017-03-01)

Implementing a Pharmacist-Led Medication Management Pilot to Improve Care Transitions
by: Rachel Root, PharmD, MS, et al.
Published: (2012-01-01)

Attitude and Perception of Physicians and Nurses Toward the Role of Clinical Pharmacists in Riyadh, Saudi Arabia: A Qualitative Study
by: Nada Alsuhebany BSPharm, PharmD, et al.
Published: (2019-11-01)

Systematic literature review of the impact of psychiatric pharmacists
by: Jessica L. Ho, PharmD, BCPP, BCPS, et al.
Published: (2024-02-01)

Pharmacist impact on medication reconciliation of behavioral health patients boarding in the emergency department
by: Mary Accomando, PharmD, BCPP, et al.
Published: (2022-06-01)

An innovative approach to teaching depression and anxiety medication management: Virtual choose your own adventure, psychiatry edition
by: Nina Vadiei, PharmD, BCPP, et al.
Published: (2023-08-01)

Severe olanzapine-induced liver function test elevation
by: Ericka Crouse, PharmD, BCPP, BCGP, FASHP, FASCP, et al.
Published: (2023-01-01)

Evaluation of Hypertriglyceridemia in Critically Ill Patients With Coronavirus Disease 2019 Receiving Propofol
by: Mary P. Kovacevic, PharmD, BCCCP, BCPS, et al.
Published: (2021-01-01)

Offering a combined resident research training program and pharmacy student elective may help improve resident publication rates
by: Brown Geoffrey PharmD, et al.
Published: (2023-08-01)

Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone
by: Lindsay M. Mailloux, PharmD, et al.
Published: (2021-01-01)

Landscape of Medication Management in the Minnesota Patient-Centered Medical Home (PCMH)
by: Donald L. Uden, PharmD, FCCP, et al.
Published: (2013-01-01)

Implementation and Impact of Critical Care Pharmacist Addition to a Telecritical Care Network
by: Rachel M. Belcher, PharmD, BCCCP, et al.
Published: (2023-01-01)

Closing the gap: Raising medical professionals' transgender awareness and medical proficiency through pharmacist-led education
by: Ardsley P. Congdon III, PharmD, BCPS, BCPP, et al.
Published: (2021-01-01)

Impact of Board Certified Psychiatric Pharmacists on improving urinary tract infection antibiotic appropriateness at an acute psychiatric hospital
by: Hamad Mohammad Adam PharmD, BCPS, et al.
Published: (2023-10-01)

DOACs in Mechanical and Bioprosthetic Heart Valves: A Narrative Review of Emerging Data and Future Directions
by: Rachel Ryu PharmD, BCPS, et al.
Published: (2022-05-01)

Venous Thromboembolism Prophylaxis in Underweight Hospitalized Patients
by: Douglas Buckheit PharmD, et al.
Published: (2021-06-01)

Optimizing Antiretroviral Therapy in Treatment-Experienced Patients Living with HIV: A Critical Review of Switch and Simplification Strategies. An Opinion of the HIV Practice and Research Network of the American College of Clinical Pharmacy
by: Daniel Chastain PharmD, BCIDP, AAHIVP, et al.
Published: (2019-09-01)

Effect of Postdismissal Pharmacist Visits for Patients Using High-Risk Medications
by: Joseph R. Herges, PharmD, BCPS, et al.
Published: (2018-03-01)

Evaluation of drug-drug interactions in hospitalized patients on medications for OUD
by: Olivia Berger, PharmD, et al.
Published: (2021-07-01)

Moving beyond first-line treatment options for OCD
by: Chris Paxos, PharmD, BCGP, BCPS, BCPP
Published: (2022-11-01)

Practices and Outcomes Associated With Sublingual Buprenorphine Use in a Critically Ill Population
by: Denis J. Vanini, PharmD, BCCCP, et al.
Published: (2024-03-01)

Post hoc depression analysis from a pharmacist-led diabetes trial
by: M. Thomas Bateman, PharmD, BCACP, et al.
Published: (2023-03-01)

Evaluating the Impact of a Pharmacist-Led Antiretroviral Stewardship Program on Reducing Drug Interactions in HIV-Infected Patients
by: Julie Anne S. Billedo PharmD, BCACP, et al.
Published: (2016-01-01)

Association of Cardiovascular Disease and Military Veteran Status With Impairments in Physical and Psychological Functioning: Retrospective Cross-Sectional Analysis of US National Survey Data
by: Nicole K. Early PharmD, BCPS, BCGP, et al.
Published: (2022-04-01)

Clinical pharmacist intervention to ensure safe stimulant prescribing practices at a Veterans Affairs facility
by: Bailey B. Bass, PharmD, BCPS, et al.
Published: (2024-02-01)

The Healthcare Future for the iGeneration: Integrating the Patient and the Healthcare System
by: Cathy H. Ficzere, PharmD, BCPS, et al.
Published: (2013-01-01)

Thromboprophylaxis in Hospitalized Non-Critically Ill Patients With Mild-to-Moderate COVID-19 Infection: A Systematic Review and Meta-Analysis
by: Awatif Hafiz PharmD, BCCP, et al.
Published: (2023-08-01)

Impact of marketing to improve patient access to care and clinic utilization for clinical pharmacy specialists
by: Nora Bairagdar, PharmD, BCPS, et al.
Published: (2023-03-01)

Safety of ECT in patients receiving an oral anticoagulant
by: Nicolette R. Centanni, PharmD, BCPS, BCGP, BCPP, et al.
Published: (2021-07-01)

Multicenter Retrospective Review of Ketamine Use in the ICU
by: Christine M. Groth, PharmD, BCCCP, FCCM, et al.
Published: (2022-02-01)

Impact of Antibiotic Shortage on H. Pylori Treatment: A Step-Wise Approach for Pharmacist Management
by: Ann Lloyd, Pharm.D., BCPS, et al.
Published: (2013-01-01)

Hyperammonemia in patients receiving valproic acid in the hospital setting: A retrospective review
by: Tressa McMorris, PharmD, BCPS, et al.
Published: (2021-07-01)

Venous Thromboembolism Prophylaxis with Enoxaparin Versus Unfractionated Heparin in Patients with Low Body Weight
by: David Michael Kaylor PharmD, et al.
Published: (2023-02-01)

Effects of Obesity on Warfarin Reversal With Vitamin K
by: Stanley A. Luc PharmD, BCPS, et al.
Published: (2019-01-01)

Evaluating the impact of an emergency department protocol that guides management of methamphetamine-induced agitation and psychosis
by: Julie Nguyen, PharmD, et al.
Published: (2022-01-01)

Coagulation Factor Xa (Recombinant), Inactivated-Zhzo (Andexanet Alfa) Hemostatic Outcomes and Thrombotic Event Incidence at an Academic Medical Center
by: Victoria M. Stevens PharmD, et al.
Published: (2019-12-01)